Olgierd S.
- Country
- Poland
- Department
- N/A
Research Overview
- Long-Term Safety and Tolerability of Atogepant for Migraine Prevention in Chronic or Episodic Migraine: A Phase 3, 156-Week Extension Study
- A Randomized, Double-blind, Parallel-group, Active Controlled Trial with Open-label Safety Extension to Evaluate the Tolerability, Safety, and Efficacy of Atogepant versus Topiramate in Subjects Requiring Preventive Treatment of Migraine (TEMPLE)
- Efficacy and Safety Evaluation of Eptinezumab for Preventive Treatment in Adults with Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 104 of 209 partner sites.
Specializations
Migraine Prevention Studies
The investigator specializes in evaluating preventive treatments for various types of migraine conditions, including research on novel therapeutic agents like eptinezumab and atogepant.
- Chronic Migraine Management
- Episodic Migraine Prevention
- Menstrual Migraine Treatment
Their work encompasses both long-term preventive approaches and targeted intervention strategies.
Therapeutic Comparisons
The investigator conducts comparative assessments between established and emerging migraine treatments, particularly focusing on the evaluation of atogepant against traditional medications like topiramate.
- Treatment Tolerability Analysis
- Safety Profile Evaluation
- Therapeutic Efficacy Assessment
Their research examines both acute and preventive treatment modalities.
Specialized Migraine Research
The investigator focuses on diverse migraine manifestations, including studies on migraine with and without aura, and evaluation of novel therapeutic compounds like MEDI0618.
- Multiple Attack Studies
- Long-term Treatment Outcomes
- Targeted Therapeutic Approaches
Their research extends to both short-term relief and sustained preventive strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.